Literature DB >> 16731859

The variable number of tandem repeats upstream of the insulin gene is a susceptibility locus for latent autoimmune diabetes in adults.

Minal Desai1, Eleftheria Zeggini, Virginia A Horton, Katharine R Owen, Andrew T Hattersley, Jonathan C Levy, Graham A Hitman, Mark Walker, Rury R Holman, Mark I McCarthy, Anne Clark.   

Abstract

The etiopathological relationship between latent autoimmune diabetes in adults (LADA) and classical type 1 (insulin dependent) diabetes remains unclear. Variation at the insulin gene variable number of tandem repeats (VNTR) minisatellite influences susceptibility to type 1 diabetes, but studies in LADA have been small and inconsistent. We examined the role of insulin gene variation (using flanking variants as surrogates for VNTR subtypes) in the largest case-control study of LADA to date (400 case and 332 control subjects). Highly significant associations were identified with disease, with dominant protective effects of the T allele at -23HphI (odds ratio [OR] 0.42 [95% CI 0.31-0.58], P=2.4 x 10(-8)), A allele at +1,404Fnu4HI (0.50 [0.36-0.70], P=3.2 x 10(-5)), and C allele at +3,580MspI (0.55 [0.35-0.85], P=0.0046). As with type 1 diabetes, the -23HphI variant (a surrogate for the subdivision of VNTR into class I and III alleles) most clearly defined susceptibility in LADA. However, there was no association with age at diagnosis or requirement for insulin therapy 6 years postdiagnosis. This study establishes that variation within the insulin gene region does influence susceptibility to LADA, with the direction and magnitude of effect indistinguishable from that previously reported for type 1 diabetes. In conclusion, differences in VNTR-encoded susceptibility do not explain the differences in clinical presentation that distinguish classical type 1 diabetes and LADA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731859     DOI: 10.2337/db06-0089

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

1.  Comment on: Gale EAM (2005) Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48:2195-2199.

Authors:  A Clark; M Desai
Journal:  Diabetologia       Date:  2006-07-11       Impact factor: 10.122

2.  Type 1 and type 2 diabetes-chalk and cheese?

Authors:  K R Owen; M I McCarthy
Journal:  Diabetologia       Date:  2009-08-01       Impact factor: 10.122

Review 3.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

4.  An association analysis of the HLA gene region in latent autoimmune diabetes in adults.

Authors:  M Desai; E Zeggini; V A Horton; K R Owen; A T Hattersley; J C Levy; M Walker; K M Gillespie; P J Bingley; G A Hitman; R R Holman; M I McCarthy; A Clark
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

Review 5.  Overlap of genetic susceptibility to type 1 diabetes, type 2 diabetes, and latent autoimmune diabetes in adults.

Authors:  Kevin J Basile; Vanessa C Guy; Stanley Schwartz; Struan F A Grant
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

6.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

7.  Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years.

Authors:  Mette K Andersen; Virve Lundgren; Joni A Turunen; Carol Forsblom; Bo Isomaa; Per-Henrik Groop; Leif Groop; Tiinamaija Tuomi
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 19.112

Review 8.  Latent (slowly progressing) autoimmune diabetes in adults.

Authors:  Jochen Seissler
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

9.  GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.

Authors:  M Desai; C A Cull; V A Horton; M R Christie; E Bonifacio; V Lampasona; P J Bingley; J C Levy; I R Mackay; P Zimmet; R R Holman; A Clark
Journal:  Diabetologia       Date:  2007-07-27       Impact factor: 10.122

10.  Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients.

Authors:  E Bakhtadze; C Cervin; E Lindholm; H Borg; P Nilsson; H J Arnqvist; J Bolinder; J W Eriksson; S Gudbjörnsdottir; L Nyström; C-D Agardh; M Landin-Olsson; G Sundkvist; L C Groop
Journal:  Diabetologia       Date:  2008-10-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.